"Understanding Long COVID: Risks, Impact, and the Protective Role of Vaccination"
Long COVID presents a significant challenge in low- and middle-income countries (LMICs) due to limited awareness and research, strained healthcare systems, and economic difficulties. Despite potentially similar prevalence rates to wealthier nations, the lack of data on long COVID in LMICs hinders advocacy and treatment efforts. Studies in various LMICs have shown high percentages of COVID-19 patients with persistent symptoms, but research is scarce, and treatments developed in richer countries may not be easily transferable. There's a need for global collaboration and data to understand long COVID's mechanisms and develop accessible treatments.